Proud to Quit (P2Q): a mobile, person-centered program to help transgender adults quit smoking
Proud to Quit (P2Q): A Person-centered mobile technology intervention for smoking cessation among transgender adults
This project offers a mobile, person-centered program to help transgender adults quit smoking and support access to gender-affirming care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11325688 on NIH RePORTER |
What this research studies
If you join, you'll use a smartphone program designed specifically for transgender adults that delivers tailored messages, tips, and links to local resources to help you stop smoking. The team will build the app with input from transgender people, then enroll adults to try the program and give feedback on how easy it is to use and whether it helps reduce or stop smoking. Participants will complete brief surveys, report their smoking and app use, and may provide simple measures like a breath carbon monoxide reading. The researchers aim to create a low-cost, scalable tool that can also help health care providers offer gender-affirming tobacco support.
Who could benefit from this research
Good fit: Adults who identify as transgender, are 21 or older, and currently smoke cigarettes and own a smartphone would be the best fit.
Not a fit: People under 21, non-smokers, those without smartphone access, or those who need urgent inpatient or high-intensity in-person treatment may not benefit from this mobile program.
Why it matters
Potential benefit: If successful, this could make it easier for transgender adults to quit smoking and improve access to gender-affirming medical care.
How similar studies have performed: Mobile smoking-cessation programs have helped many adults quit, but approaches specifically tailored to transgender adults are relatively new and less tested.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Sun, Christina Jiayi — University of Colorado Denver
- Study coordinator: Sun, Christina Jiayi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.